Addition of cilostazol to conventional dual antiplatelet therapy reducing the risk of cardiac events and restenosis after drugeluting stent implantation:a metaanalysis
Backgrounds Relative efficacy and safety of triple antiplatelet therapy(TAT,addition of cilostazol to aspirin and clopidogrel)compared with conventional dual antiplatelet therapy(DAT,aspirin and clopidogrel)remained controversial.Objectives This meta-analysis was performed to compare the risk of cardiac events and restenosis of TAT versus DAT in drug-eluting stents(DES)implantation patients.
Zhangwei Chen
Zhongshan Hospital Affilated to Fudan University,Shanghai 200032,China
国内会议
广州
英文
179-179
2012-04-11(万方平台首次上网日期,不代表论文的发表时间)